Results 71 to 80 of about 1,511 (168)

Preference for a fixed combination of brinzolamide/timolol versus dorzolamide/ timolol among patients with open-angle glaucoma or ocular hypertension

open access: yesClinical Ophthalmology, 2013
Ana Sanseau,1 Juan Sampaolesi,2 Emilio Rintaro Suzuki Jr,3 Joao Franca Lopes,4 Hector Borel51Instituto de la Visión, Ciudad de Buenos Aires, Argentina; 2Consultorio Oftalmologico Sampaolesi, Ciudad de Buenos Aires, Argentina; 3Oftalmoclinica ...
Sanseau A   +4 more
doaj  

24-h Efficacy of Glaucoma Treatment Options [PDF]

open access: yes, 2016
Current management of glaucoma entails the medical, laser, or surgical reduction of intraocular pressure (IOP) to a predetermined level of target IOP, which is commensurate with either stability or delayed progression of visual loss.
Banu, Bozkurt.   +8 more
core   +1 more source

Tools for clinical pharmacists to identify medications that can cause drug‐induced cognitive impairment: A systematic review

open access: yesJACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 7, Issue 12, Page 1207-1227, December 2024.
Abstract Cognitive impairment affects around 19% of community‐dwelling older adults in the United States. Pharmacists can play a significant role in identifying and deprescribing cognitive‐impairing medications through cognitive‐focused medication reviews or as part of comprehensive medication management.
Jacob Stanton   +4 more
wiley   +1 more source

Brinzolamide ophthalmic suspension: a review of its pharmacology and use in the treatment of open angle glaucoma and ocular hypertension

open access: yesClinical Ophthalmology, 2008
Michele IesterClinica Oculistica, University of Genoa, ItalyAbstract: Brinzolamide is a white powder commercially formulated as a 1% ophthalmic suspension to reduce intraocular pressure (IOP).
Michele Iester
doaj  

BRINZOLAMIDE-INDUCED EYE DISCHARGE: A RARE ENTITY [PDF]

open access: yes, 2016
A 62-year-old lady diagnosed to have normal tension glaucoma was receiving triple therapy of topical brinzolamide, timolol, and careprost. Postapplication of brinzolamide eye drops patient experienced mucoid eye discharge starting 10 minutes after ...
A, Krishna Rao   +3 more
core   +1 more source

A COMPREHENSIVE CHEMICAL CHARACTERIZATION OF IN SITU OPHTHALMIC GEL [PDF]

open access: yes, 2021
In situ ophthalmic gel is a gel preparation that is initially in the form of ophthalmic solution that dripped into the eye and then the solution turns into a gel after contact with the surface of the eye.
KURNIAWANSYAH, INSAN SUNAN   +4 more
core   +1 more source

Elimination profile of low‐dose chlortalidone and its detection in hair for doping analysis—Implication for unintentional non‐therapeutic exposure

open access: yesDrug Testing and Analysis, Volume 16, Issue 11, Page 1378-1383, November 2024.
An elimination of low‐dose chlortalidone and hydrochlorothiazide (HCTA) was conducted on five consecutive days in two volunteers. The urine concentrations were measured by LC–MS/MS. The chlortalidone concentration 10 days after the last ingestion of a sub‐therapeutic dose would have still caused an adverse analytical finding in an athlete's sample ...
Detlef Thieme   +5 more
wiley   +1 more source

Daily Costs and Cost Effectiveness of Glaucoma Fixed Combinations in China [PDF]

open access: yes, 2020
Background. The aim of this study was to compare the daily costs and cost effectiveness of fixed combination glaucoma drugs in China. Methods. This study included the following fixed combination drugs: brinzolamide 1% and timolol 0.5% (Azarga; Alcon, Inc.
Guo, Ruru   +4 more
core   +1 more source

A Novel Mutation of FOXC1 (P136L) in an Axenfeld–Rieger Syndrome Patient With a Systematized Delusion of Jealousy: A Case Report and Literature Review

open access: yesMolecular Genetics &Genomic Medicine, Volume 12, Issue 11, November 2024.
The proband (II‐3) and his son (III‐3) have ARS by whole exome sequencing. The audiogram shows bilateral sensorineural hearing loss (red, right ear; blue, left ear). Brain magnetic resonance imaging data from the patient (T2‐weighted‐fluid‐attenuated inversion recovery).
Yuta Yoshino   +2 more
wiley   +1 more source

Efficiency, safety, and patient preference of switching from dorzolamide 1%/timolol 0.5% to brinzolamide 1%/timolol 0.5% while maintaining the prostaglandin F2α analog

open access: yesClinical Ophthalmology, 2015
Yoshie Shimizu,1 Shunsuke Nakakura,1 Makiko Nishiyama,1 Hitoshi Tabuchi,1 Yoshiaki Kiuchi2 1Department of Ophthalmology, Saneikai Tsukazaki Hospital, Himeji, 2Department of Ophthalmology and Visual Sciences, Graduate School of Biomedical Sciences ...
Shimizu Y   +4 more
doaj  

Home - About - Disclaimer - Privacy